Cancer BiologybioRxiv
ABHD17 enzymes regulate dynamic plasma membrane palmitoylation and N-Ras-dependent cancer growth
J. R. Remsberg, R. M. Suciu, N. A. Zambetti…·B. F. Cravatt
This study identifies ABD957, a selective ABHD17 inhibitor, which disrupts N-Ras depalmitoylation and inhibits NRAS-mutant AML growth, suggesting potential as a targeted therapy.
DOI 10.1038/s41589-021-00785-8